GlycoPulse

GlycoPulse is a medical technology company developing a next-generation platform for the continuous, real-time monitoring of metabolic biomarkers. Spun out of the Massachusetts Institute of Technology (MIT), the company leverages advanced optical sensing techniques, including Raman spectroscopy, to provide high-fidelity data on analytes such as glucose and lactate. Their proprietary technology aims to overcome the limitations of current electrochemical sensors by offering multi-analyte detection and improved long-term stability. The platform is designed for integration into wearable devices, targeting applications in chronic disease management, critical care, and athletic performance optimization. By providing a more comprehensive view of metabolic health, GlycoPulse seeks to empower patients and clinicians with actionable, non-invasive insights.